Efficacy and Safety of Oral Ritlecitinib for the Treatment of Patients With Active Nonsegmental Vitiligo
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of the American Academy of Dermatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Efficacy and Safety of Oral Ritlecitinib for the Treatment of Active Nonsegmental Vitiligo: A Randomized Phase 2b Clinical Trial
J Am Acad Dermatol 2022 Nov 09;[EPub Ahead of Print], K Ezzedine, E Peeva, Y Yamaguchi, LA Cox, A Banerjee, G Han, I Hamzavi, AK Ganesan, M Picardo, D Thaçi, JE Harris, JM Bae, K Tsukamoto, R Sinclair, AG Pandya, A Sloan, D Yu, K Gandhi, MS Vincent, B KingFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.